In Response to President Trump’s Request to Bring Pharmaceutical Production Back to America, Villya Pharmaceuticals Announces Breakthrough Patent for Enhancing Solubility of Medications
MELBOURNE, Fla., Feb. 11, 2025 /PRNewswire/ -- Villya Pharmaceuticals, based in Melbourne, Florida, is excited to announce the granting of U.S. Patent No. 12,115,222 B2, titled "Compositions and Methods for